Diagnostic Performance of Serum Asialo α1-Acid Glycoprotein Levels to Predict Liver Cirrhosis

Background/AimsTo date, studies on various noninvasive techniques have been suggested to evaluate the degree of liver fibrosis. We aimed to investigate the diagnostic performance of serum asialo α1-acid glycoprotein (AsAGP) in the diagnosis of liver cirrhosis compared with chronic hepatitis for clin...

Full description

Saved in:
Bibliographic Details
Published in:Gut and liver 2021, 15(1), , pp.109-116
Main Authors: Lim, Dae Hyun, Kim, Mimi, Jun, Dae Won, Kwak, Min Jung, Yoon, Jai Hoon, Lee, Kang Nyeong, Lee, Hang Lak, Lee, Oh Young, Yoon, Byung Chul, Choi, Ho Soon, Kang, Bo Kyeong
Format: Article
Language:English
Subjects:
asialo alpha 1-acid glycoprotein
chronic hepatitis
liver cirrhosis
magnetic resonance elastography
Original
내과학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background/AimsTo date, studies on various noninvasive techniques have been suggested to evaluate the degree of liver fibrosis. We aimed to investigate the diagnostic performance of serum asialo α1-acid glycoprotein (AsAGP) in the diagnosis of liver cirrhosis compared with chronic hepatitis for clinically useful result. MethodsWe conducted a case-control study of 96 patients with chronic liver disease. Chronic hepatitis was defined as the presence of chronic liver disease on ultrasonography, with a liver stiffness of less than 5.0 kPa as shown on magnetic resonance elastography (MRE). Liver cirrhosis was defined as liver stiffness of more than 5.0 kPa on MRE. The serum AsAGP concentration was compared between the two groups. ResultsSerum AsAGP levels were significantly higher in patients with cirrhosis than in those with chronic hepatitis (1.83 µg/mL vs 1.42 µg/mL, p
ISSN:1976-2283
2005-1212
DOI:10.5009/gnl19282